Skip to content
HeyJared

Mike

Trading without illusions. Market analysis, entry logic, discipline. Sharing my journey with 9+ years of experience. Simple ideas → consistent execution.

Newsletter · By Mike | Market Behavior & Edge · Official site

Indexed issues, last 90 days
10
Latest publication
Sep 30, 2026
Audience
Checking…
Earliest in this view
Sep 15, 2026

Latest issues

  1. Issue · Sep 30, 2026

    L1 vs L2: Why the Same Transaction Can Cost a Cent in One Place and a Lunch in Another (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="971" src="https://substackcdn.com/image/fetch/$s_!SzpE!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb9d6dc0f-5a6f-4e8a-a2b6-a753662485c5_1536x1024.pn

  2. Issue · Sep 24, 2026

    The Copy-Paste King Strikes Again: How Meta’s "Muse" Outmaneuvered ChatGPT (opens the original)

    Excerpt · Neutral tone

    Read excerpt

    <img alt="" class="sizing-normal" height="819" src="https://substackcdn.com/image/fetch/$s_!ce5c!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7cfbe86d-5499-4246-aac1-ee35cedf6568_1672x941.png"

  3. Issue · Sep 24, 2026

    The Next-Gen siRNA Frontier: APARx Pharmaceuticals ($ADRX) Files for Nasdaq IPO Backed by Tier-1 Syndicate & AbbVie Alliance (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="784" src="https://substackcdn.com/image/fetch/$s_!PEFp!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F59293f6d-4c05-44c9-8a83-6e5b5985966d_1168x784.jpe

  4. Issue · Sep 23, 2026

    The Hidden Quantum Bottleneck: How IonQ Broke the Multi-Billion-Dollar Decoder Trap (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="832" src="https://substackcdn.com/image/fetch/$s_!U0AE!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F80865cfa-5454-42ee-b40f-3bf55b09464b_1248x832.jpe

  5. Issue · Sep 22, 2026

    The Best-in-Class Metabolic Disruptor: Dissecting Viking Therapeutics ($VKTX) (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="971" src="https://substackcdn.com/image/fetch/$s_!AfuS!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbd77648c-7b11-4920-9c14-3ec1a032b478_1536x1024.pn

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Mike